APM
ELV icon

Avidity Partners Management’s Elevance Health ELV Stock Holding History

Avidity Partners Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-207,600
Closed -$94.3M – 93
2022
Q3 		$94.3M Sell
207,600
-233,400
-53% -$112M 1.92% 19
2022
Q2 		$213M Buy
441,000
+41,600
+10% +$20.6M 4.89% 4
2022
Q1 		$196M Buy
399,400
+78,400
+24% +$35.8M 4.09% 5
2021
Q4 		$149M Buy
+321,000
New +$135M 3.16% 8
2020
Q4 		– Sell
-176,400
Closed -$47.4M – 106
2020
Q3 		$47.4M Buy
+176,400
New +$47.5M 2.2% 15

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Avidity Partners Management's ELV Position: Q4 2022 in Review

Avidity Partners Management sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 207,600 shares — an estimated $94.3M sold.

Avidity Partners Management first reported a position in ELV in Q3 2020 and held it in 5 quarters. The position peaked at $213M in Q2 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Avidity Partners Management reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • Avidity Partners Management sold 207,600 Elevance Health shares in Q4 2022, an estimated $94.3M.
  • Avidity Partners Management first reported a position in Elevance Health in Q3 2020 and held it in 5 quarters.
  • Avidity Partners Management's Elevance Health position peaked at $213M in Q2 2022.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Avidity Partners Management's 13F filing for Q4 2022, filed 14 Feb 2023.